Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 480-485

  Wilker, Elissa H ^a   Alexeeff, Stacey E ^a   Poon, Audrey ^b   Litonjua, Augusto A ^b   Sparrow, David ^c   Vokonas, Pantel S ^c   Mittleman, Murray A ^a,d   Schwartz, Joel ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Cardiovascular disease; Endothelial dysfunction; Inflammation; SNPs

Indexed keywords

COLECALCIFEROL RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FIBRINOGEN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 2; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ASTHMA; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGING; ASTHMA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FIBRINOGEN; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 70349414487     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.004     Document Type: Article

References (29)

1. Bielinski S.J., Pankow J.S., Foster C.L., et al. Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination. Atherosclerosis 199 (2008) 172-178
2. Brull D.J., Serrano N., Zito F., et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 (2003) 2063-2069
3. Danik J.S., and Ridker P.M. Genetic determinants of C-reactive protein. Curr Atheroscler Rep 9 (2007) 195-203
4. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
5. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 107 (2003) 499-511
6. Hingorani A.D., Shah T., Casas J.P., Humphries S.E., and Talmud P.J. C-reactive protein and coronary heart disease: predictive test or therapeutic target?. Clin Chem (2008)
7. Siegerink B., Rosendaal F.R., and Algra A. Genetic variation in fibrinogen; its relation to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost (2008)
8. Haverslag R., Pasterkamp G., and Hoefer I.E. Targeting adhesion molecules in cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 8 (2008) 252-260
9. Suh E. Allergic disease may increase the risk of atherosclerosis. Thorax 61 (2006) 299
10. Knoflach M., Kiechl S., Mayr A., et al. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med 165 (2005) 2521-2526
11. Barnes P.J. Mechanisms in COPD: differences from asthma. Chest 117 (2000) 10S-14S 10.1378/chest.117.2_suppl.10S
12. Bell B., Rose C.L., and Damon A. The Veterans Administration longitudinal study of healthy aging. Gerontologist 6 (1966) 179-184
13. Roberts W.L., Moulton L., Law T.C., et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 47 (2001) 418-425
14. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 17 (1957) 237-246
15. Sun X., Ding H., Hung K., and Guo B. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res 28 (2000) e68
16. Purcell S., Neale B., Todd-Brown K., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 (2007) 559-575
17. Schwartz J., Park S.K., O'Neill M.S., et al. Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction. Am J Respir Crit Care Med 172 (2005) 1529-1533
18. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
19. Kim P.Y., Stewart R.J., Lipson S.M., and Nesheim M.E. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease. J Thromb Haemost 5 (2007) 1250-1256
20. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
21. Calcagni E., and Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 1069 (2006) 62-76
22. Drolet G., and Rivest S. Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides 22 (2001) 761-767
23. Patterson R.L., Boehning D., and Snyder S.H. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 73 (2004) 437-465
24. Dolmetsch R.E., Xu K., and Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392 (1998) 933-936
25. Aihara K., Azuma H., Akaike M., et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279 (2004) 35798-35802
26. Wu-Wong J.R. The potential for vitamin D receptor activation in cardiovascular research. Expert Opin Investig Drugs 16 (2007) 407-411
27. Ortlepp J.R., Krantz C., Kimmel M., et al. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol 105 (2005) 90-95
28. Kammerer C.M., Dualan A.A., Samollow P.B., et al. Bone mineral density, carotid artery intimal medial thickness, and the vitamin D receptor BsmI polymorphism in Mexican American women. Calcif Tissue Int 75 (2004) 292-298
29. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc, Series B 57 (1995) 289-300